Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Product: photon-therapeutics.com
Photon Therapeutics is a multinational medical technology company headquartered in the UK, founded by experts in clinical ophthalmology and ophthalmic research. Its core R&D focuses on low-dose UVC phototherapy devices for corneal infections in humans and animals. The veterinary version, PhotonUVC Vet, is already available on the market, while the human version is still under active development. Its team consists of experts across clinical ophthalmology, medical R&D, and business operations, and its core technology is backed by patents and published academic research.
The flagship product PhotonUVC Vet uses a patented 226nm-wavelength low-dose UVC. A 5-second non-contact treatment can inactivate target infectious microorganisms while remaining safe for host tissue. It works for corneal infections, corneal ulcers, and conjunctivitis caused by bacteria, viruses, and fungi, and is compatible with most veterinary species from small pets to cattle and horses. A single charge supports at least 100 treatments, and built-in sensors calibrate dosage in real time to ensure treatment accuracy.
The official website does not disclose specific pricing. Customers need to contact the team via email to purchase. Payments are accepted in EUR, USD, and GBP. Instalment financing is only available for customers based in the UK, and the company ships to veterinary clinics worldwide.
Advantages: This device fills a clinical need for broad-spectrum anti-infective treatment that avoids antibiotic resistance and microbiota disruption. Its technical specifications and safety have been academically verified, and its medical-grade accuracy far outperforms cheap consumer UV products. It is also simple and easy to operate.
Disadvantages: Pricing is not publicly available on the website, and purchasing requires email correspondence, making the process less convenient. Only the veterinary version is currently available for purchase, and the human product has not yet launched.
This device is suitable for adoption by all types of pet hospitals and veterinary clinics around the world, to use as a primary or supplementary treatment for corneal infection cases.
Users in mainland China can access the official website directly, no VPN proxy is required, and all public content can be browsed normally.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on photon-therapeutics.com official site.
photon-therapeutics.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach photon-therapeutics.com directly.